Search research articles
Contact Us
Filters
Showing results (41-50 of 222) with videos related to
Page
of 23
Sort By:
Wellcome Open Research
|
April 19, 2021
Hepatitis B virus resistance to tenofovir: fact or fiction? A systematic literature review and structural analysis of drug resistance mechanisms
Jolynne Mokaya, Anna L McNaughton, Phillip A Bester, et al.
Journal of Proteome Research
|
March 18, 2011
New approaches for biomarker discovery: the search for liver fibrosis markers in hepatitis C patients
Bevin Gangadharan, Robin Antrobus, David Chittenden, et al.
Nature Communications
|
March 19, 2025
Complement-mediated enhancement of SARS-CoV-2 antibody neutralisation potency in vaccinated individuals
Jack Mellors, Raman Dhaliwal, Stephanie Longet, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 10, 2024
Cost-Effectiveness of Hepatocellular Carcinoma Surveillance Strategies in Patients With Compensated Liver Cirrhosis in the United Kingdom
Osvaldo Ulises Garay, Louisa Elena Ambühl, Thomas G Bird, et al.
Abdominal Radiology (New York)
|
November 28, 2020
Liver cT<sub>1</sub> decreases following direct-acting antiviral therapy in patients with chronic hepatitis C virus
Arjun N A Jayaswal, Christina Levick, Jane Collier, et al.
Eclinicalmedicine
|
May 18, 2023
Disparities in care and outcomes for primary liver cancer in England during 2008-2018: a cohort study of 8.52 million primary care population using the QResearch database
Weiqi Liao, Carol A C Coupland, Hamish Innes, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 23, 2017
Increases in IgE, Eosinophils, and Mast Cells Can be Used in Diagnosis and to Predict Relapse of IgG4-Related Disease
Emma L Culver, Ross Sadler, Adrian C Bateman, et al.
Hepatology (Baltimore, Md.)
|
March 21, 2022
A pan-genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice
Timothy Donnison, Joey McGregor, Senthil Chinnakannan, et al.
Trials
|
May 20, 2020
The design and statistical aspects of VIETNARMS: a strategic post-licensing trial of multiple oral direct-acting antiviral hepatitis C treatment strategies in Vietnam
Leanne McCabe, Ian R White, Nguyen Van Vinh Chau, et al.
Plos One
|
July 5, 2012
Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study
Bevin Gangadharan, Manisha Bapat, Jan Rossa, et al.
Page
of 23
Search research articles
Search
Showing results (41-50 of 222) with videos related to
Sort By:
Page
of 23
Wellcome Open Research
|
April 19, 2021
Hepatitis B virus resistance to tenofovir: fact or fiction? A systematic literature review and structural analysis of drug resistance mechanisms
Jolynne Mokaya, Anna L McNaughton, Phillip A Bester, et al.
Journal of Proteome Research
|
March 18, 2011
New approaches for biomarker discovery: the search for liver fibrosis markers in hepatitis C patients
Bevin Gangadharan, Robin Antrobus, David Chittenden, et al.
Nature Communications
|
March 19, 2025
Complement-mediated enhancement of SARS-CoV-2 antibody neutralisation potency in vaccinated individuals
Jack Mellors, Raman Dhaliwal, Stephanie Longet, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 10, 2024
Cost-Effectiveness of Hepatocellular Carcinoma Surveillance Strategies in Patients With Compensated Liver Cirrhosis in the United Kingdom
Osvaldo Ulises Garay, Louisa Elena Ambühl, Thomas G Bird, et al.
Abdominal Radiology (New York)
|
November 28, 2020
Liver cT<sub>1</sub> decreases following direct-acting antiviral therapy in patients with chronic hepatitis C virus
Arjun N A Jayaswal, Christina Levick, Jane Collier, et al.
Eclinicalmedicine
|
May 18, 2023
Disparities in care and outcomes for primary liver cancer in England during 2008-2018: a cohort study of 8.52 million primary care population using the QResearch database
Weiqi Liao, Carol A C Coupland, Hamish Innes, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 23, 2017
Increases in IgE, Eosinophils, and Mast Cells Can be Used in Diagnosis and to Predict Relapse of IgG4-Related Disease
Emma L Culver, Ross Sadler, Adrian C Bateman, et al.
Hepatology (Baltimore, Md.)
|
March 21, 2022
A pan-genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice
Timothy Donnison, Joey McGregor, Senthil Chinnakannan, et al.
Trials
|
May 20, 2020
The design and statistical aspects of VIETNARMS: a strategic post-licensing trial of multiple oral direct-acting antiviral hepatitis C treatment strategies in Vietnam
Leanne McCabe, Ian R White, Nguyen Van Vinh Chau, et al.
Plos One
|
July 5, 2012
Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study
Bevin Gangadharan, Manisha Bapat, Jan Rossa, et al.
Page
of 23